Survival Time of Rats Exposed to Different High Oxygen Pressures after Administration of Perfluorochemicals

  • M. Stark
  • J. Lutz
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 215)


Hyperbaric oxygen administration is considered useful in the treatment of anaerobic infections (Cline and Turnbull, 1985) as well as in tumour radiation therapy (Fischer, Rockwell and Martin, 1986) where very high tissue partial pressures of oxygen are needed. The most commonly used oxygen pressure of 300 kPa (3 ATA) may not be sufficient to reach this goal. There must be sufficient oxygen capacity in the blood to maintain an elevated partial pressure even at the venous end of capillaries when oxygen is consumed. More effective treatment could be accomplished if haemoglobin were to remain in the oxygenated form. The administration of perfluorochemicals (PFC) which increase the oxygen capacity under elevated oxygen partial pressure can help in attaining this goal. However, as judged from previous results obtained by Geyer (1983), hyperbaric oxygen treatment combined with PFC administration can be expected to augment oxygen toxicity considerably. To test this supposition hyperbaric oxygen was applied and survival times were measured in rats as an index of the overall tolerance of the organism at various oxygen pressures. Survival time was found to give a more precise endpoint than the determination of the onset of convulsions. It was the goal of this study to establish the relationship between oxygen tension and lethal duration of exposure in both control and PFC-treated animals.


Survival Time Oxygen Pressure Hyperbaric Oxygen Confidence Band Anaerobic Infection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Clark, J.M. (1984). Interacting effects of hypoxia and acute hypercapnia on oxygen tolerance in rats. J. Appl. Physiol. 56, 1191–1198.Google Scholar
  2. Cline, K.A. and Turnbull, T.L (1985).. Clostridial myonecrosis. Ann. Emerg. Med. 14, 459–466.Google Scholar
  3. Fischer, J.J., Rockwell, S. and Martin, D.F. (1986). Perfluorochemicals and hyperbaric oxygen in radiation therapy. Int. J. Radiol. Oncol. Biol. Phys. 12, 95–102.Google Scholar
  4. Gerschman, R., Gilbert, L. and Caccamise, D. (1958). Effect of different substances on survival times of mice exposed to different high oxygen tensions. Amer. J. Physiol. 192, 563–571.Google Scholar
  5. Geyer, R. (1983). PFC as a blood substitute–an overview. In: Advances in Blood Substitutes Research. Eds Bolin, R.B., Geyer, R.P. and Nemo, G.J., Alan R. Liss, New York, pp. 157–168.Google Scholar
  6. Lutz, J. and Herrmann, G. (1984). Perfluorochemicals as a treatment of decompression sickness in rats. Pflugers Arch. 401, 174–177.CrossRefGoogle Scholar
  7. Mitsuno, T., Ohyanagi, H. and Naito, R. (1982). Clinical studies of perfluorochemical whole-blood substitutes (Fluosol-DA). Ann. Surg. 195, 60–69.Google Scholar
  8. Tremper, K.K., Friedman, A.E., Levine, E.M., Lapin, P.R. and Camarillo, D. (1982). The preoperative treatment of severely anemic patients with a perfluorochemical oxygen-transport fluid, Fluosol-DA. N. Engl. J. Med. 307, 277–283.Google Scholar

Copyright information

© Plenum Press, New York 1987

Authors and Affiliations

  • M. Stark
    • 1
  • J. Lutz
    • 1
  1. 1.Physiologisches InstitutUniversitaet WuerzburgWuerzburgGermany

Personalised recommendations